Footnotes Update on FDAs ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity FDA.gov
Most probably, the observation period of six months was too short to sensitively detect worsening in visual outcomes, including GCL volume loss, also proven by a recent study in which a delayed decline in visual field and GCL volume after 12 months was seen [39]
Supportive Tools for Ongoing Wellness While Eden is not involved in clinical care, the platform offers a suite of digital tools that may help individuals stay organized and engaged throughout their health journey
Schedule a consultation with a Klarity Health provider to discuss your specific situation and explore appropriate solutions tailored to your health profile and goals
Combined with the increased lipolysis (fat breakdown) and thermogenesis (fat burning), the net effect on body composition is more favorable than what either GLP-1 or GIP agonism can produce alone
Patients received an initial dose of either 1 mg, 2 mg, or 4 mg of retatrutide and subsequent doses of either 1 mg, 4 mg, 8 mg, or 12 mg, or they received a placebo throughout the 48 weeks of the study
